Dr. Magliato is involved with the following medical technology companies either as an officer, advisor, or board member:
JARVIK HEART INC. – this company has developed an artificial heart technology that uses an axial flow pump to support the heart in patients with severe heart failure as a bridge to transplant. For the past 6 years, Dr. Magliato has served as the Chairman of the Clinical Events Committee for the US human clinical trial that is currently underway. www.jarvikheart.com
The Clinical Event Committee reviewing cases
The Clinical Event Committee - Mitch Elkind, MD, Hal Wasserman,MD, Magliato, MD, and Dr. Robert Jarvik (inventor of the artificial Jarvik heart)
Dr. Kathy Magliato with Dr. Robert Jarvik (inventor of the Jarvik Heart). Dr. Magliato is holding the artificial heart in her hand.
Contact information for Dr. Robert Jarvik:
Robert Jarvik, MD
Jarvik Heart
333 W. 52nd Street
New York, NY 10019
Tel: 212-397-3911 x30
Fax: 212-397-3919
Contact information for Dr. Mitchell Elkind:
Mitchell S. V. Elkind, MD, MS, FAAN
Associate Professor of Neurology
Associate Chairman of Neurology for Clinical Research and Training
Columbia University
710 West 168th Street, Room 642
New York, NY 10032
Tel: 212-305-1710
Fax: 212-305-1658
Email: mse13@columbia.edu
Contact information for Dr. Hal Wasserman:
Hal S. Wasserman, MD
Director, Cardiac Catheterization Laboratory
Director, Interventional Cardiovascular Services
Associate Clinical Professor of Medicine
Columbia University College of Physicians and Surgeons
Danbury Hospital, 24 Hospital Avenue, Danbury, CT 06810
Tel: 203-739-7600
Fax: 203-739-7044
Email: hal.wasserman@danhosp.org
http://www.danburyhospital.org
